The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training
Nielson, E. M., & Guss, J. | Journal of Psychedelic Studies | 22 August 2018
Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
Psilocybin and Mental Health–Don’t Lose Control
Barnby, J. M., & Mehta, M. A. | Frontiers in Psychiatry | 3 July 2018
Positive psychology in the investigation of psychedelics and entactogens: A critical review
Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. | Neuropharmacology | 29 June 2018
High dose psilocybin is associated with positive subjective effects in healthy volunteers
Nicholas, C. R., Henriquez, K. M., Gassman, M. C., Cooper, K. M., Muller, D., Hetzel, S., ... & Hutson, P. R. | Journal of Psychopharmacology | 27 June 2018
Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics
Mason, N. L., & Kuypers, K. P. | Journal of Psychedelic Studies | 25 June 2018
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 25 June 2018
Psychedelics and hypnosis: Commonalities and therapeutic implications
Lemercier, C. E., & Terhune, D. B. | Journal of Psychopharmacology | 25 June 2018
Effects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. | Acta Psychiatrica Scandinavica | 19 June 2018
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects
Vizeli, P., & Liechti, M. E. | PloS one | 18 June 2018
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., ... & Tófoli, L. F. | Psychological medicine | 15 June 2018
Psychedelics Promote Structural and Functional Neural Plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., ... & Duim, W. C. | Cell reports | 12 June 2018
Dark Classics in Chemical Neuroscience: Mescaline
Cassels, B., & Sáez-Briones, P. | ACS chemical neuroscience | 8 June 2018
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
Mash, D. C., Duque, L., Page, B., & Allen-Ferdinand, K. | Frontiers in Pharmacology | 5 June 2018
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. | Neuropharmacology | 5 June 2018
A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens
Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018
Psychedelic therapy as a complementary treatment approach for alcohol use disorders
Eischens, P., & Atherton, W. L. | Journal of Psychedelic Studies | 30 May 2018
Psilocybin and MDMA reduce costly punishment in the Ultimatum Game
Gabay, A. S., Carhart-Harris, R. L., Mazibuko, N., Kempton, M. J., Morrison, P. D., Nutt, D. J., & Mehta, M. A. | Scientific reports | 29 May 2018
Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
Cata-Preta, E. G., Serra, Y. A., Moreira-Junior, E. D. C., Reis, H. S., Kisaki, N. D., Libarino-Santos, M., ... & Costa, J. L. | Frontiers in pharmacology | 29 May 2018
Psychedelic use and intimate partner violence
Thiessen, M. S., Walsh, Z., Bird, B. M., & Lafrance, A. | Journal of psychopharmacology | 29 May 2018
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Duman, R. S. | F1000Research | 24 May 2018
Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging
T. L’Estrade, E., Hansen, H. D., Erlandsson, M., Ohlsson, T. G., Knudsen, G. M., & Herth, M. M. | ACS Chemical Neuroscience | 15 May 2018
Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF)
Ramachandran, V., Chunharas, C., Marcus, Z., Furnish, T., & Lin, A. | Neurocase | 15 May 2018
Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
Whelan, A., & Johnson, M. I. | Pain management | 3 May 2018
The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018